Reduction of Plasma Levels of Soluble Tumor Necrosis Factor and Interleukin-2 Receptors by Means of a Novel Immunoadsorption Column-Reference-Cited by-同舟云学术

Reduction of Plasma Levels of Soluble Tumor Necrosis Factor and Interleukin-2 Receptors by Means of a Novel Immunoadsorption Column

Published:2008-12 Issue:6 Volume:12 Page:491-499
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:

Author:

Lentz Meredith,Kumar Kiran

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-9987.2008.00640.x/fullpdf

Reference9 articles.

1. In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality;Israel;Isr J Med Sci,1978

2. The phylogeny of oncology;Lentz;Mol Biother,1990

3. The role of therapeutic apheresis in the treatment of cancer: a review;Lentz;Ther Apher,1999

4. Soluble tumour necrosis factor receptors as prognostic factors in cancer patients;Langkopf;Lancet,1994

5. Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo;Selinsky;Cell Immunol,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy;Cancers;2021-02-02

2. SERUM LEVELS OF TUMOR NECROSIS FACTOR (TNF-A) AND ITS SOLUBLE RECEPTORS STNF-R1 AND STNF-R2 IN CANCER PATIENTS;Russian Journal of Oncology;2012-02-15

3. The Italian registry of therapeutic apheresis: Granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study;Journal of Clinical Apheresis;2011-11-09

4. The tumour necrosis factor as a mediator of vessel inflammation: importance of exposed receptor residues for its neutralization;Hematology;2009-12

5. Letter to the Editor;Therapeutic Apheresis and Dialysis;2009-08